GlassScriptPhysician profile
Alfonso Ciervo
NPI 1457346918
$946.32
in general payments reported to CMS, 2019-2025
13 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.26 · 2020: $40.27 · 2021: $140 · 2022: $114 · 2023: $175 · 2024: $184 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $504.45 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Synecor Biomaterial, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic, INC. | $140.19 | 2021 | |
| Intuitive Surgical, INC. | $98.43 | 2022 | |
| Endologix LLC | $40.27 | 2020 | |
| Davol INC. | $29.88 | 2019 | |
| Abiomed | $23.94 | 2025 | |
| Smith+Nephew, INC. | $18.70 | 2025 | Stravix Pl |
| Cardiovascular Systems INC. | $16.91 | 2019 | |
| Boston Scientific Corporation | $15.45 | 2022 | |
| Eisai INC. | $14.75 | 2019 | |
| Array Biopharma INC | $14.72 | 2019 | |
| Amgen INC. | $14.37 | 2023 | Repatha |
| Inari Medical, INC. | $14.26 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfonso Ciervo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.